UNITY Biotechnology

Unity Biotechnology, Inc. designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and designs senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected.
Type
Private
HQ
San Francisco, US
Founded
2009
Size (employees)
7 (est)
UNITY Biotechnology was founded in 2009 and is headquartered in San Francisco, US

Key People/Management at UNITY Biotechnology

M.S. Keith R. Leonard

M.S. Keith R. Leonard

Chief Executive Officer
Bob Goeltz

Bob Goeltz

Chief Financial Officer
Nathaniel David

Nathaniel David

President
Jamie Dananberg

Jamie Dananberg

Chief Medical Officer
D. Dan Marquess

D. Dan Marquess

Chief Scientific Officer
Tamara Tompkins

Tamara Tompkins

General Counsel
Tammy Rose

Tammy Rose

Vice President of Regulatory Affairs
Yan Poon

Yan Poon

Vice President of Biology
Huw Tanner

Huw Tanner

Vice President of Portfolio, Alliance, and Project Management
Derek Ragusa

Derek Ragusa

Vice President of Product Team Leadership
Pedro Beltran

Pedro Beltran

Senior Vice President of Biology
Robert Nelsen

Robert Nelsen

Co-Founder and Managing Director, ARCH Venture Partners
Kristina Burow

Kristina Burow

Managing Director, ARCH Venture Partners
Camille Samuels

Camille Samuels

Partner, Venrock
Graham Cooper

Graham Cooper

Former Chief Financial Officer, Receptos, Inc
Jan van Deursen

Jan van Deursen

Professor of Biochemistry and Molecular Biology at the Mayo Clinic; Professor of Pediatrics at the Mayo Clinic
Judith Campisi

Judith Campisi

Professor at the Buck Institute for Research on Aging; Professor at Lawrence Berkeley National Laboratory
Daohong Zhou

Daohong Zhou

Professor of Pharmaceutical Sciences, University of Arkansas for Medical Sciences

UNITY Biotechnology Office Locations

UNITY Biotechnology has an office in San Francisco
Show all (1)

UNITY Biotechnology Financials and Metrics

Summary Metrics

Founding Date

2009

Total Funding

$118.8 m

Latest funding size

$116 m

Time since last funding

over 1 year

Investors

UNITY Biotechnology's latest funding round in October 2016 was reported to be $116 m. In total, UNITY Biotechnology has raised $118.8 m

UNITY Biotechnology's Web-traffic and Trends

UNITY Biotechnology Online and Social Media Presence

UNITY Biotechnology Company Life and Culture

You may also be interested in